07/24/2024
6:45 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
5:40 PM | Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/15/2024
7:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:09 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
3:10 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
11:48 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:00 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
07/09/2024
3:01 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2024
3:02 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:03 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
07/08/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
4:09 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
06/12/2024
4:11 PM | Virpax Pharmaceuticals (Filer)
| Form ARS | |
05/14/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
05/13/2024
4:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
05/13/2024
3:02 PM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
8:54 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/30/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/18/2024
3:17 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/26/2024
7:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:22 PM | Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:22 PM | Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:24 PM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:26 PM | Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
9:11 AM | SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
7:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
7:58 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
8:08 AM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
12/07/2023
7:50 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/17/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
11/17/2023
6:15 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
3:51 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
2:03 PM | Virpax Pharmaceuticals (Filer)
| Form NT 10-Q | |
10/11/2023
3:10 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
8:51 AM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
8:28 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
4:00 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4/A | |
08/16/2023
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
